Sulbutiamine


Synthetic disulfide thiamine derivative

A lipophilic disulfide thiamine analog that crosses the blood-brain barrier; developed in Japan for asthenia and used as a nootropic.

Abstract

Sulbutiamine (isobutyryl thiamine disulfide; CAS 3286-46-2; molecular formula C32H46N8O6S2; molecular weight 702.89) is a synthetic disulfide derivative of thiamine (vitamin B1) developed in Japan in the 1960s and approved in several Asian and European markets under the trade name Arcalion. The compound is structurally a dimer of two thiamine molecules joined by a disulfide bridge, conferring high lipophilicity and improved blood-brain barrier penetration compared to thiamine itself. Mechanism: thiamine prodrug; sulbutiamine is metabolized to thiamine in the brain, raising central thiamine concentrations and supporting thiamine-dependent enzymes (transketolase, pyruvate dehydrogenase, alpha-ketoglutarate dehydrogenase). Clinical use is in psychogenic asthenia and as a nootropic; evidence is from clinical trials with mixed methodology. Plasma half-life is approximately 5 hours. Used as a lipophilic thiamine prodrug in research and nootropic communities.

FOR RESEARCH USE ONLY. Not for medical, diagnostic, or therapeutic purposes. Not for human or animal consumption. All information is provided for research and educational purposes only.


Browse all monographs

Previous monograph
Next monograph